Power3 Medical files patent application on markers, test for breast cancer

New York, Dec. 20 - Power3 Medical Products, Inc. said it has filed a provisional patent application with the U.S. Patent and Trademark Office for breast cancer protein biomarkers in blood serum and their use in a test for breast cancer.

By monitoring the blood serum concentrations of a group of blood serum proteins and then subjecting the results to biostatistical analysis, scientists at Power3 were able to demonstrate discrimination between three groups of women, women with breast cancer, women with benign breast disease and normal women with no detectable breast cancer, the company said. In addition, some of the biomarkers demonstrated differences between early and late stage disease.

The company said it believes the test may be able to find breast cancers that are missed by mammography and detect cancers at an earlier stage.

Power3 is a Woodlands, Texas, proteomics company.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.